Mossad also mobilized vaccine information war, we missed betting opportunities in September and October

It turned out that the government was very willing to introduce Pfizer, Moder or vaccine from the beginning. This is because both vaccines are the first mRNA (messenger RNA) methods to be tried. Therefore, it was evaluated that the company focused on the traditional AstraZeneca vaccine, and failed in the information war because it did not properly grasp the progress of clinical trials of Pfizer/Moder or vaccines.

A high-ranking government official said on the 23rd, “When discussing the April Corona 19 vaccine, experts consistently expressed skepticism that Pfizer-Modena’s mRNA vaccine is a method that has never been successful in the world. I did it.” “It was difficult to hit more than 100,000 people a day for Pfizer-Modern vaccines even with the total mobilization of domestic capabilities, and it was determined that it was not a structure capable of digesting it because storage and transportation facilities were not available.”

On the other hand, it was positive for AstraZeneca. The official said, “We concluded that AstraZeneca’s carrier-based vaccines are traditional and highly reliable, and that they can be sufficiently supplied and stored under the current drug distribution system.” Explained. As SK Bioscience took over the consignment production of AstraZeneca vaccine, the government decided to receive 8 million doses of domestic production in August, and then increased it to 20 million doses in negotiations. Since I was already in a situation with AstraZeneca, I made contact with Pfizer and Modena, but they gave little weight.

But since then, things have changed dramatically. Pfizer’s vaccine began phase 3 clinical trials on July 27 and announced interim results on November 9. The Modena vaccine also began phase 3 clinical trials on July 27, and interim results were released on November 16. An official familiar with the Pan-Government Vaccine and Treatment TF said, “Even experts were not able to ask exactly which vaccine and how much to buy. We collected the information in our own way, but we missed the opportunity in September and October.” He said in particular, “I should have bet on Pfizer Modena and I couldn’t.”

As a result, the government was unable to obtain information properly even though the clinical trials of the two vaccines were progressing very quickly, and it was already difficult to use in mid- and late November. It contrasts with the Israeli government, which has also mobilized Mossad, an intelligence agency. Mossad responded by operating an overseas information network to understand information such as the progress of clinical trials, safety, and effectiveness.

A senior government official also said, “I had great confidence in Celltrion’s antibody treatment.” He said, “It has been reported that there is a high possibility that the Celltrion antibody treatment will be developed first in the world, and we were very excited about it.” “It was said that the phase 3 clinical trial could be completed by the end of the year.” In addition, he added, “We called the Celltrion technical team to confirm the principle of the antibody treatment and the possibility of success from various angles, and we evaluated that there is considerable evidence.” It means that it did not put much weight on vaccines because of expectations for antibody treatments.

An official who was familiar with the pan-government vaccine and treatment TF said, “At the time, the atmosphere of the meeting was to swear even if the vaccine remained, if it was insufficient, or if it was expensive. I thought it would be difficult to avoid criticism in any way, and now it is a reality.” He said, “If you had money like the United States, you could have pre-purchased with just 1 trillion won.

Reporter Shin Seong-shik, reporter Lee Tae-yoon [email protected]